Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001850207 | SCV002282463 | uncertain significance | Hypertrophic cardiomyopathy | 2022-04-28 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 845 of the MYBPC3 protein (p.Arg845Gly). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MYBPC3-related conditions. ClinVar contains an entry for this variant (Variation ID: 180973). |
All of Us Research Program, |
RCV001850207 | SCV004827127 | uncertain significance | Hypertrophic cardiomyopathy | 2023-06-28 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001541900 | SCV001760544 | uncertain significance | Cardiomyopathy | no assertion criteria provided | clinical testing |